Literature DB >> 29588756

The Role of Bioresorbable Scaffolds in Meeting the Challenges of Bifurcations.

Axel Schmermund1, Holger Eggebrecht1.   

Abstract

Side branches are frequently related to periprocedural complications. Considering any side branches >1 millimetres (mm), side branch occlusion or reduced flow may occur in approximately 10 % of interventional procedures. First data indicate that bioresorbable vascular scaffolds (BVS) behave similar compared with modern drug-eluting stents (DES) with regard to compromising or occluding sizeable side branches. Although technically more demanding compared with modern DES, it appears to be feasible to dilate side branches after crossing BVS cells. Preliminary data suggest at least balloon diameters up to 2.5 mm can be used, but safety remains unclear. Instead of kissing balloon dilatation, rather sequential balloon dilatation should be employed. Anecdotic evidence suggests BVS can be used even in relatively complex coronary anatomy, e.g. bifurcations distal to chronic total occlusion. Certainly more data are needed. As of today, BVS offer promise not only for the treatment of simple coronary lesions but also bifurcations. Given successful side branch protection, they might allow for restoring the native coronary anatomy in the sense of restitutio ad integrum.

Entities:  

Keywords:  Bioresorbable vascular scaffold; coronary bifurcation; periprocedural myocardial infarction; side branch occlusion

Year:  2013        PMID: 29588756      PMCID: PMC5808676          DOI: 10.15420/icr.2013.8.2.87

Source DB:  PubMed          Journal:  Interv Cardiol        ISSN: 1756-1485


  17 in total

1.  From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?

Authors:  Patrick W Serruys; Hector M Garcia-Garcia; Yoshinobu Onuma
Journal:  Eur Heart J       Date:  2011-10-31       Impact factor: 29.983

2.  Drug-eluting stents for coronary bifurcations: bench testing of provisional side-branch strategies.

Authors:  John A Ormiston; Mark W I Webster; Seifeddin El Jack; Peter N Ruygrok; James T Stewart; Douglas Scott; Erin Currie; Monique J Panther; Bronwyn Shaw; Barbara O'Shaughnessy
Journal:  Catheter Cardiovasc Interv       Date:  2006-01       Impact factor: 2.692

3.  [A new classification of coronary bifurcation lesions].

Authors:  Alfonso Medina; José Suárez de Lezo; Manuel Pan
Journal:  Rev Esp Cardiol       Date:  2006-02       Impact factor: 4.753

4.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

5.  Functional formula to determine adequate balloon diameter of simultaneous kissing balloon technique for treatment of bifurcated coronary lesions: clinical validation by volumetric intravascular ultrasound analysis.

Authors:  Yoshihiro Morino; Hirosada Yamamoto; Kazuaki Mitsudo; Masakazu Nagaoka; Hiroki Takeuchi; Nami Okamoto; Kumiko Kozuma; Atsushi Matsuzaki; Kengo Tanabe; Kazuhiro Hara; Teruhisa Tanabe; Yuji Ikari
Journal:  Circ J       Date:  2008-06       Impact factor: 2.993

6.  Use of BVS in a chronic total occlusion with bifurcation lesion.

Authors:  Toru Naganuma; Sandeep Basavarajaiah; Azeem Latib; Charis Costopoulos; Antonio Colombo
Journal:  Int J Cardiol       Date:  2013-05-03       Impact factor: 4.164

7.  Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process.

Authors:  Juan Luis Gutiérrez-Chico; Frank Gijsen; Evelyn Regar; Jolanda Wentzel; Bernard de Bruyne; Leif Thuesen; John Ormiston; Dougal R McClean; Stephan Windecker; Bernard Chevalier; Dariusz Dudek; Robert Whitbourn; Salvatore Brugaletta; Yoshinobu Onuma; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2012-04       Impact factor: 11.195

8.  Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.

Authors:  Annapoorna S Kini; Paul Lee; Jonathan D Marmur; Ajay Agarwal; Mary E Duffy; Michael C Kim; Samin K Sharma
Journal:  Am J Cardiol       Date:  2004-01-01       Impact factor: 2.778

9.  Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.

Authors:  Takashi Muramatsu; Yoshinobu Onuma; Hector M García-García; Vasim Farooq; Christos V Bourantas; Marie-Angèle Morel; Xiaolin Li; Susan Veldhof; Antonio Bartorelli; Robert Whitbourn; Alexandre Abizaid; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2013-03       Impact factor: 11.195

10.  Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents.

Authors:  Jeffrey J Popma; Laura Mauri; Charles O'Shaughnessy; Paul Overlie; Brent McLaurin; Alexandra Almonacid; Ajay Kirtane; Martin B Leon
Journal:  Circ Cardiovasc Interv       Date:  2009-04-01       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.